Not cancer · Austria
Fatty liver disease (MASLD/MASH)
How is it diagnosed today? It is usually found after blood tests or scans done for another reason show signs of problems with your liver. NHS
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.6 open trials in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Questions for your doctorReady lists to print or copy before your next visit.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Weight loss, healthy diet and exercise. NHS
2 medicines are approved for this disease in Austria:
- Resmetirom (Rezdiffra) – approved in 2025
- Semaglutide (Kayshild, Wegovy Multi FixDose) – approved in 2026
An EU approval is valid in Austria. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Being tested in people
6 open trials in Austria, 271 worldwide. See the trials
- ALN-CIDEB (Phase 3)
- DR10624 Injection (Phase 3)
- Efimosfermin alfa (Phase 3)
- Efruxifermin (Phase 3)
Only in the lab or in animals
Of the 20 newest articles, 2 were in animals and 0 in the lab. See them
No proof it works
We checked 13 things people say help with this disease against the research. See how far each has been tested
No trial in people on record yet:
- Cannabis and cannabinoids (CBD, THC) (only single reports in people)
- Amygdalin (laetrile, "vitamin B17") (animal studies only)
- Mistletoe extract (animal studies only)
- Ivermectin (lab studies only)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
0 open trials in Austria with these filters
We found no open trial in Austria with these filters.
Available abroad (31 trials)
Nearest region first. Travel and treatment abroad are often not paid for; ask your health insurer first.
Tests BI 3804379 Doses in Healthy People and Liver Fibrosis Patients
NCT06575400 · ClinicalTrials.gov
Countries: Belgium
- Edegem, Belgium – SGS Life Science Services - Clinical Research
Ages 18 to 65
Contact the trial teamTests TGM-312-SC01 safety in healthy adults and adults with MASH liver disease
NCT07427680 · ClinicalTrials.gov
Countries: United Kingdom
- London, United Kingdom – Richmond Pharmacology
Ages 18 to 70
Contact the trial teamStudies how hormone replacement therapy affects fatty liver disease in menopausal women
NCT06704516 · ClinicalTrials.gov
Countries: United Kingdom
- Oxford, United Kingdom – Oxford Centre for Diabetes Endocrinology and Metabolism (OCDEM), Churchill Hospital
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamA Phase I Study to Evaluate Single and Multiple Subcutaneous Administrations of QLS2406-1 Injection in Chinese Adult Participants With Overweight and Obesity.
NCT07937787 · ClinicalTrials.gov
Ages 18 to 55
Contact the trial teamResmetirom in adults with fatty liver disease MASH and heart failure
NCT07830758 · ClinicalTrials.gov
Countries: United States
- Fort Myers, United States – Covenant Metabolic Specialist
- Oxnard, United States – FOMAT - Clinicas Mi Salud
- Peoria, United States – Arizona Clinical Trials
Age 18 and over
Contact the trial teamTests INI-822 safety in healthy people and people with MASH liver disease
NCT05945537 · ClinicalTrials.gov
Countries: Australia
- Bedford Park, Australia – Flinders Medical Centre, Flinders Medical Centre, Flinders
- Birtinya, Australia – University of the Sunshine Coast Clinical Trials (Birtinya), UniSC Clinical Trials Vitality Village, Level 4, Tenancy 410, 5 Discovery Court
- Box Hill, Australia – Box Hill Hospital, Level 1, 5 Arnold street
Ages 18 to 70
Contact the trial teamEfimosfermin alfa in adults with liver impairment from fatty liver disease
NCT07358546 · ClinicalTrials.gov
Countries: United States
- Houston, United States – hospital not given
- Miami Lakes, United States – hospital not given
- Rialto, United States – hospital not given
Ages 18 to 70
Contact the trial teamPlant protein versus animal protein supplements for alcohol-related fatty liver disease
NCT07897981 · ClinicalTrials.gov
Countries: China
- Hangzhou, China – Zhejiang Chinese Medical University
Ages 18 to 74
Contact the trial teamHow the body handles one dose of HRS-4729 in people with kidney problems
NCT07807059 · ClinicalTrials.gov
Countries: China
- Chengdu, China – Sichuan Provincial People's Hospital
Ages 18 to 65
Contact the trial teamTesting ACT500 tablets for safety in adults with fatty liver disease
NCT07462455 · ClinicalTrials.gov
Countries: China
- Beijing, China – Beijing Tsinghua Changgeng Hospital
- Shanghai, China – Xinhua Hospital Affiliated To Shanghai Jiao tong University School of Medicine
- Xiamen, China – The First Affiliated hospital of Xiamen University
Ages 18 to 69
Contact the trial teamTesting the safety of MWN105 injections in people with overweight or obesity
NCT07803809 · ClinicalTrials.gov
Countries: China
- Kunming, China – The First Affiliated Hospital of Yunnan University of Chinese Medicine (Yunnan Provincial Hospital of Traditional Chinese Medicine)
Ages 18 to 50
Contact the trial teamTests tirzepatide effects on the liver in people with fatty liver disease and obesity
NCT06934642 · ClinicalTrials.gov
Countries: United States
- Albuquerque, United States – University of New Mexico Health Sciences Center
Ages 18 to 75
Contact the trial teamTests VV-14303 gene therapy for fatty liver disease called MASH
NCT07732400 · ClinicalTrials.gov
Countries: New Zealand, United States
- Auckland, New Zealand – hospital not given
- Chandler, United States – hospital not given
- Lady Lake, United States – hospital not given
Ages 18 to 75
Contact the trial teamSafety study of OPK-88006 in healthy adults and adults with fatty liver disease
NCT07512427 · ClinicalTrials.gov
Countries: United States
- Miami, United States – hospital not given
Ages 18 to 75
Contact the trial teamTests alpelisib's effect on insulin and liver sugar and fat
NCT06354088 · ClinicalTrials.gov
Countries: United States
- New York, United States – Columbia University Irving Medical Center
Ages 18 to 70
Contact the trial teamPET Scans Study Liver and Brain Inflammation in Fatty Liver Disease
NCT06453915 · ClinicalTrials.gov
Countries: United States
- Sacramento, United States – UC Davis EXPLORER Molecular Imaging Center
Age 18 and over
Contact the trial teamTests diazoxide against placebo in adults with obesity and fatty liver disease
NCT07403604 · ClinicalTrials.gov
Countries: United States
- New York, United States – Columbia University Irving Medical Center
Ages 18 to 65
Contact the trial teamDihydroartemisinin, a malaria medicine, tested for fatty liver disease in adults
NCT07679542 · ClinicalTrials.gov
Countries: China
- Nanjing, China – The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu 210029
Ages 18 to 45
Contact the trial teamHigh-protein diet for fatty liver disease caused by alcohol
NCT07632222 · ClinicalTrials.gov
Ages 30 to 65
Contact the trial teamBicalutamide Compared With Placebo in Young Women With Fatty Liver and PCOS
NCT05979389 · ClinicalTrials.gov
Countries: United States
- San Francisco, United States – University of California San Francisco
Ages 18 to 42
Contact the trial teamTesting ALN-PNP safety in healthy adults and adults with fatty liver disease
NCT05648214 · ClinicalTrials.gov
Countries: United States
- Glendale, United States – California Clinical Trials Medical Group
- Houston, United States – Pioneer Research Solutions
- Los Angeles, United States – Velocity Clinical Research
Ages 18 to 75
Contact the trial teamTests XTYW007 capsules in healthy adults and adults with high LDL cholesterol
NCT07407634 · ClinicalTrials.gov
Countries: China
- Jilin City, China – The First Hospital of Jilin University
Ages 18 to 65
Contact the trial teamTesting how lowering insulin levels affects liver sugar and fat making in insulin resistance
NCT06558422 · ClinicalTrials.gov
Countries: United States
- New York, United States – Columbia University Irving Medical Center
Ages 18 to 65
Contact the trial teamRifaximin-α for metabolic dysfunction-associated fatty liver disease
NCT07381257 · ClinicalTrials.gov
Countries: China
- Shanghai, China – Changzheng Hospital, Naval Medical University, shanghai, China
Ages 18 to 75
Contact the trial teamTests erdosteine in adults with fatty liver disease not caused by alcohol
NCT07242222 · ClinicalTrials.gov
Countries: Egypt
- Tanta, Egypt – Tanta Unuversity
Ages 18 to 60
Contact the trial teamCilostazol for People With Nonalcoholic Fatty Liver Disease
NCT07238985 · ClinicalTrials.gov
Countries: Egypt
- Damietta, Egypt – Mostafa Bahaa
Ages 18 to 60
Contact the trial teamTesting Henggliejin for Fatty Liver in Type 2 Diabetes Patients
NCT07198516 · ClinicalTrials.gov
Ages 18 to 70
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTesting rifaximin in people with fatty liver disease linked to metabolism
NCT07185932 · ClinicalTrials.gov
Countries: China
- Shanghai, China – Changzheng Hospital, Naval Medical University, shanghai, China
Ages 18 to 75
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests B1344 injections in adults with fatty liver disease
NCT07128797 · ClinicalTrials.gov
Countries: China
- Beijing, China – Beijing Tsinghua Changgung Hospital (BTCH) affiliated to Tsinghua University
- Datong, China – Sinopharm Tongmei General Hospital
- Guangzhou, China – Nanfang Hospital, Southern Medical University
Ages 18 to 75
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests IMM-H014 safety in adults with fatty liver inflammation
NCT07016633 · ClinicalTrials.gov
Countries: China
- Changchun, China – The First Bethune Hospital of Jilin University
Ages 18 to 65
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests QX1206 in adults with type 2 diabetes and fatty liver disease
NCT06694935 · ClinicalTrials.gov
Countries: Canada
- Toronto, Canada – Centricity Research Toronto LMC.
Ages 18 to 64
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial team
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- ReviewStage-Dependent Roles of PANoptosis in MASLD: From Isolated Steatosis to Hepatocellular Carcinoma.Cell Biochem Funct · 2026-11-01
- In peopleBioinformatics and Machine Learning Identify Key Genes in Mitochondrial Homeostasis and Immune Infiltration in Metabolic Dysfunction-Associated Steatotic Liver Disease Progression.Biomed Res Int · 2026-01-01
- KASL Consensus Statement for Pharmacologic Treatment of Metabolic Dysfunction-Associated Steatohepatitis: Focus on Semaglutide.Clin Mol Hepatol · 2026-11-17
- Cardiometabolic index fails to discriminate the histological status of metabolic dysfunction-associated steatotic liver disease patients: A report from biopsy-proven Turkish metabolic dysfunction-associated steatotic liver disease cohort.Hepatol Forum · 2026-10-30
- In peopleClinical Impact of the AISF STEPS-MASH Algorithm: Real-World Application in Tertiary Hepatology Practice.Liver Int · 2026-12-01
Is it true?
Saw something on social media? Fact-check it now.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Hepatitis Hilfe Österreich – Plattform Gesunde Leber
Nationwide non-profit patient organisation for all liver diseases, founded in 1999 by patients: counselling, information leaflets and support for patients and relatives.
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (4)
- European Liver Patients' Association (ELPA)
European umbrella of national liver patient groups: liver disease information, HCC patient guide (with ESMO), clinical trial finder and liver cancer advocacy; points patients to member groups.
- Global Liver Institute (GLI)
Global liver health advocacy body with a Liver Cancers Council, patient/caregiver education events and advocate training; not a direct support service.
Phone: +1 800 845 5910
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Questions for your doctor
Ready lists for a new diagnosis, during treatment, before a trial and before you pay. Open the question lists
Not medical advice. We show what is open and what is known; your care team decides what fits you.